title: [Toll-like receptor 4 expression mediates the activation of platelets induced by LPS].
abstract: The study was aimed to investigate the expression of Toll-like receptor 4 (TLR4) on platelets and to determine whether platelet TLR4 involves in its activation induced by lipopolysaccharide (LPS). Human platelet-rich plasma (PRP) and platelet suspension obtained from 15 healthy individuals pretreated with a concentration of 0.2 microg/ml of LPS in the presence or absence of thrombin (1 U/ml) for 1 hour. The expressions of TLR4, CD62P (P-select) and CD40L on platelets were detected by flow cytometry, and platelet TLR4 expression was further determined by Western blot analysis. The results indicated that the percentage of TLR4-positive platelets induced by thrombin was increased by 32.34% compared with the resting platelets (25.44%, p < 0.05). TLR4 expression on platelets treated with LPS was remarkably elevated in the presence or absence of thrombin. However, the expression level of the former was much higher than that of the latter and thrombin stimulation alone (p < 0.05). Moreover, the similar results were found in Western blot analysis. Synchronously, expressions of CD62P and CD40L on resting platelets were 6.39% and 2.45%, they were also markedly increased when treated with thrombin (42.68% and 14.8%) and LPS respectively, and the increases of expression of CD62P and CD40L were more significant when stimulated with both LPS and thrombin (63.03% and 13.94%). Although anti-TLR4 antibody inhibited significantly the increase of TLR4, CD62P and CD40L on platelets induced by LPS, which did not affect their increase induced by thrombin. In conclusion, the evidence has been shown that functional TLR4 can be expressed on human platelets. It may involve in platelet activation as an important mediator of LPS-induced CD62P and CD40L expressions on platelets.
authors.affiliation: Department of Hematology, The Second Hospital, Sun Yat-Sen University, Guangzhou 510120, Guangdong Province, China. mlp215yahoo.com.cn
authors.forename: Li-Ping
authors.initials: LP
authors.lastname: Ma
authors.forename: Jing
authors.initials: J
authors.lastname: Wei
authors.forename: Jian-Xing
authors.initials: JX
authors.lastname: Chang
authors.forename: Cheng
authors.initials: C
authors.lastname: Zhang
authors.forename: Zhi-Xin
authors.initials: ZX
authors.lastname: Pei
authors.forename: Qiu-Hong
authors.initials: QH
authors.lastname: Yang
mesh_terms: D000328:Adult; D001792:Blood Platelets / Q000378:metabolism*; D023201:CD40 Ligand / Q000235:genetics; D006801:Humans; D008070:Lipopolysaccharides / Q000494:pharmacology*; D008875:Middle Aged; D019007:P-Selectin / Q000378:metabolism; D015539:Platelet Activation; D051197:Toll-Like Receptor 4 / Q000378:metabolism*
chemical_list: D008070:Lipopolysaccharides; D019007:P-Selectin; C495345:TLR4 protein, human; D051197:Toll-Like Receptor 4; D023201:CD40 Ligand